Jubilant Pharma Limited is engaged in manufacturing and supply of Radiopharmaceuticals with a network of more than 45 Radiopharmacies in the US, Allergy …
Jubilant Biosys Limited provides innovation and collaborative research to global pharmaceutical innovators through…
Jubilant Therapeutics Inc. is an innovative patient-centric biopharmaceutical company developing breakthrough therapies in the area of oncology and auto-immune disorders.…
Corporate Social Responsibility (CSR) is deeply imbibed in the Company’s approach towards sustainable development.
Jubilant Therapeutics Inc. reports isoform-selective PAD4 inhibitors
Come and Join Jubilant Pharmova for exploring unending opportunities and give your career the right direction.
JBI-802 is a first-in-class, orally administered, dual equipotent inhibitor of LSD1 & HDAC6